Michael Wollner, MD | |
14023 Southwest Fwy, Sugar Land, TX 77478 | |
(281) 325-4100 | |
Not Available |
Full Name | Michael Wollner |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 24 Years |
Location | 14023 Southwest Fwy, Sugar Land, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477588192 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | L3528 (Texas) | Secondary |
208M00000X | Hospitalist | L3528 (Texas) | Primary |
207P00000X | Emergency Medicine | A88300 (California) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hermann Hospital System | Houston, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Memorial Hermann Medical Group | 7012008360 | 590 |
News Archive
CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today it has completed the validation of all critical utilities and manufacturing equipment at its GMP manufacturing facility in Maryland.
Cellvax is a French service company which provides complete in vitro & in vivo preclinical innovating services allowing to accelerate the drug development process for unmet needs related with severe human diseases, mainly in oncology field.
Boston Medical Center has been approved for a $13.5 million award by the Patient-Centered Outcomes Research Institute to test the efficacy of two different methods of delivering cognitive behavioral therapy - face to face or online - to children with anxiety.
Healthcare practitioners and researchers have a new tool to combat obesity in primary care settings, according to a study published in Obesity, the flagship journal of The Obesity Society.
› Verified 7 days ago
Entity Name | Memorial Hermann Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today it has completed the validation of all critical utilities and manufacturing equipment at its GMP manufacturing facility in Maryland.
Cellvax is a French service company which provides complete in vitro & in vivo preclinical innovating services allowing to accelerate the drug development process for unmet needs related with severe human diseases, mainly in oncology field.
Boston Medical Center has been approved for a $13.5 million award by the Patient-Centered Outcomes Research Institute to test the efficacy of two different methods of delivering cognitive behavioral therapy - face to face or online - to children with anxiety.
Healthcare practitioners and researchers have a new tool to combat obesity in primary care settings, according to a study published in Obesity, the flagship journal of The Obesity Society.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Wollner, MD 909 Frostwood Dr Ste 1.100, Houston, TX 77024-2301 Ph: (713) 338-4523 | Michael Wollner, MD 14023 Southwest Fwy, Sugar Land, TX 77478 Ph: (281) 325-4100 |
News Archive
CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today it has completed the validation of all critical utilities and manufacturing equipment at its GMP manufacturing facility in Maryland.
Cellvax is a French service company which provides complete in vitro & in vivo preclinical innovating services allowing to accelerate the drug development process for unmet needs related with severe human diseases, mainly in oncology field.
Boston Medical Center has been approved for a $13.5 million award by the Patient-Centered Outcomes Research Institute to test the efficacy of two different methods of delivering cognitive behavioral therapy - face to face or online - to children with anxiety.
Healthcare practitioners and researchers have a new tool to combat obesity in primary care settings, according to a study published in Obesity, the flagship journal of The Obesity Society.
› Verified 7 days ago
Dr. Vickas Dangayach, M.D.,MBA Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 16811 Southwest Fwy Fl 3, Sugar Land, TX 77479 Phone: 281-276-0836 Fax: 281-275-0760 | |
Ms. Mahpara Bushra Khaliq, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 16811 Southwest Fwy Ste 300, Sugar Land, TX 77479 Phone: 281-276-0836 | |
Samir Joglekar, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 16605 Southwest Fwy, Suite 175, Sugar Land, TX 77479 Phone: 713-777-5334 Fax: 713-429-5207 | |
Naveen Sajja, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 16655 Southwest Fwy, Sugar Land, TX 77479 Phone: 281-274-7000 | |
Sidrah Sheikh, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 16655 Southwest Fwy, Sugar Land, TX 77479 Phone: 281-276-0836 Fax: 281-276-8544 | |
Salman S. Aly, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6903 Brisbane Ct Ste 100, Sugar Land, TX 77479 Phone: 832-886-4774 | |
Dr. Aaliya Islam Amer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6514 Highway 90a Ste 100, Sugar Land, TX 77498 Phone: 281-313-0100 Fax: 281-699-2151 |